AGP Executive Report
Last update: 6 hours agoEbola Alert Hits Home: The CDC confirmed one American tested positive for Ebola after work exposure in the Democratic Republic of Congo, with six high-risk contacts being moved to Germany; officials say the risk to the U.S. public remains low as the WHO treats the outbreak as a global emergency. Cancer Watch: FDA granted priority review for Bayer’s frontline sevabertinib (Hyrnuo) in HER2-mutated NSCLC, while AstraZeneca and Daiichi Sankyo won new U.S. approvals for Enhertu in two HER2-positive early breast cancer settings. Drug Pricing Fight: The Supreme Court rejected drugmakers’ appeals over Medicare’s negotiated-price program under the Inflation Reduction Act, leaving lower-court rulings in place. Policy Pressure: Tennessee AG Skrmetti led a 23-state letter challenging a climate-science chapter in a federal judges’ evidence manual as biased toward one side. Care Delivery & Oversight: FDA inspection counts keep rising in some counties (e.g., Madera, Gallatin), underscoring ongoing compliance scrutiny.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
